Prostate Cancer Industry, May 2015 Market Reports from Top Publishers

You might be interested in: Drug, Diagnostics, Molecular Diagnostic, Oncology, Biomarker, Biopsy Device, Healthcare, Hormone, Pharmaceutical, Urology Device, Cancer Diagnostic, Clinical Trial, Radiopharmaceutical, Ultrasound, Vaccine.


 
1-10 of 79 reports for Prostate Cancer

Purchase Reports From Reputable Market Research Publishers

Global Prostate Cancer Therapeutics Market to 2020

Global Prostate Cancer Therapeutics Market to 2020

  • $ 1 000
  • Industry report
  • May 2015
  • by Igate Research

Prostate Cancer remains a top priority for health systems around the world as incidence level rises, fueled by growing and aging populations. The main drivers for the prostate cancer market are the increase ...

 Metastatic Prostate Cancer-Pipeline Insights, 2015

Metastatic Prostate Cancer-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Metastatic Prostate Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Metastatic Prostate Cancer. The main objective of this ...

 Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2015

Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Metastatic Hormone Refractory Prostate Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Metastatic Hormone Refractory Prostate ...

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2015

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2015,report provides Metastatic Hormone Refractory (Castration Resistant, ...

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2015

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2015,report provides Hormone Refractory (Castration Resistant, Androgen-Independent) ...

Metastatic Prostate Cancer-API Insights, 2015

Metastatic Prostate Cancer-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Metastatic Prostate Cancer-API Insights, 2015,report provides Metastatic Prostate Cancer drugs marketed details and API Manufacturers details across the globe along with the location. ...

Prostate Cancer-API Insights, 2015

Prostate Cancer-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Prostate Cancer-API Insights, 2015,report provides Prostate Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives ...

The 2016-2021 World Outlook for Prostate Cancer Therapeutics

The 2016-2021 World Outlook for Prostate Cancer Therapeutics

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for prostate cancer therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

Prostate Cancer Partnering 2010-2015

Prostate Cancer Partnering 2010-2015

  • $ 995
  • Industry report
  • March 2015
  • by Currentpartnering

The Prostate cancer Partnering 2010-2015 report provides understanding and access to the prostate cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends ...

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive ...

About 5 600 reports for Prostate Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Nigeria

  • March 2015
    158 pages
  • Cancer  

    Oncology  

    Prostate Cancer  

  • Nigeria  

    Africa  

    United States  

View report >

Pathology Description

January 2013

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.